seragy Launches with €12 Million Financing to Advance Quantitative Biomarkers for Neurodegenerative Diseases
Seragy to Expand Lab and Team in Hanover
Biotechnology
seragy - the Seed Biomarker Strategy Company. Our aim is to decode pathological protein aggregation and to reveal the molecular fingerprints behind proteopathies such as Alzheimer's, Parkinson’s, and ALS. These fingerprints reflect distinct disease subtypes and can correlate to disease ...
View start-up
Biotechnology
Armed Cell Therapeutics is a biotechnology company developing next-generation armed CAR-T therapies for cancer. Its lead programs focus on non-Hodgkin lymphoma, where relapse after current CAR-T therapy remains common, and small cell lung cancer, an aggressive tumor with few effective treatment ...
View start-up
Biotechnology
Undecimal Bio is a breakthrough platform biotechnology with its own internal pipeline. Our core mission is to revolutionize the delivery of RNA therapeutics by harnessing combinatorial chemistry and AI to address unmet clinical needs across multiple disease ...
View start-up
© 1997-2026 LUMITOS AG, All rights reserved